(+)-artemisinin multiple interactions ISO RGD:735254 6480464 [parthenolide co-treated with artemisinin co-treated with Quercetin] inhibits the reaction [15-hydroxy-5 more ... CTD PMID:23355332 (5Z,8Z,11Z,13E)-15-HETE multiple interactions ISO RGD:735254 6480464 [parthenolide co-treated with artemisinin co-treated with Quercetin] inhibits the reaction [15-hydroxy-5 more ... CTD PMID:23355332 (5Z,8Z,11Z,13E)-15-HETE increases secretion ISO RGD:735254 6480464 15-hydroxy-5 more ... CTD PMID:23355332 1,2,4-trimethylbenzene decreases expression ISO RGD:3026 6480464 pseudocumene results in decreased expression of LYZ protein CTD PMID:17337753 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of LYZ2 mRNA CTD PMID:22206623 1-Ethyl-2-benzimidazolinone affects secretion ISO RGD:735254 6480464 1-ethyl-2-benzimidazolinone affects the secretion of LYZ protein CTD PMID:15234967 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of LYZ2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:3026 6480464 Ethinyl Estradiol results in increased expression of LYZ mRNA CTD PMID:15834898 , PMID:17351261 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of LYZ2 mRNA CTD PMID:17942748 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of LYZ2 mRNA CTD PMID:15598610 17beta-estradiol multiple interactions ISO RGD:3026 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYZ2 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO RGD:735254 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of LYZ mRNA CTD PMID:20660070 17beta-estradiol 3-benzoate multiple interactions ISO RGD:3026 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYZ2 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of LYZ2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:3026 6480464 Tetrachlorodibenzodioxin results in increased expression of LYZ2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:3026 6480464 Tetrachlorodibenzodioxin results in decreased expression of LYZ mRNA CTD PMID:19692669 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LYZ mRNA, Tetrachlorodibenzodioxin affects the expression of LYZ2 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735254 6480464 Tetrachlorodibenzodioxin results in increased expression of LYZ mRNA CTD PMID:21998131 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LYZ2 mRNA CTD PMID:16114106 , PMID:21041162 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LYZ mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of LYZ mRNA CTD PMID:17982090 , PMID:18200517 2,5-hexanedione decreases expression ISO RGD:3026 6480464 2, 5-hexanedione results in decreased expression of LYZ2 mRNA CTD PMID:22952946 2,5-hexanedione increases expression ISO RGD:3026 6480464 2, 5-hexanedione results in increased expression of LYZ2 mRNA CTD PMID:22952946 2-butoxyethanol increases expression EXP 6480464 n-butoxyethanol results in increased expression of LYZ2 mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:3026 6480464 3 more ... CTD PMID:20959002 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:3026 6480464 3 more ... CTD PMID:19692669 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of LYZ2 mRNA CTD PMID:20188158 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LYZ2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LYZ2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of LYZ mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:735254 6480464 Decitabine results in increased expression of LYZ mRNA CTD PMID:19194470 5-aza-2'-deoxycytidine multiple interactions ISO RGD:735254 6480464 [Decitabine results in decreased methylation of LYZ gene] which results in increased expression of LYZ mRNA CTD PMID:17000900 5-aza-2'-deoxycytidine decreases methylation ISO RGD:735254 6480464 Decitabine results in decreased methylation of LYZ gene CTD PMID:17000900 5-azacytidine increases expression ISO RGD:735254 6480464 Azacitidine results in increased expression of LYZ mRNA CTD PMID:19194470 6-propyl-2-thiouracil increases expression ISO RGD:3026 6480464 Propylthiouracil results in increased expression of LYZ2 mRNA CTD PMID:24780913 aconitine increases expression ISO RGD:3026 6480464 Aconitine results in increased expression of LYZ2 protein CTD PMID:33236894 aflatoxin B1 increases expression ISO RGD:3026 6480464 Aflatoxin B1 results in increased expression of LYZ2 mRNA CTD PMID:25378103 all-trans-retinoic acid decreases expression ISO RGD:735254 6480464 Tretinoin results in decreased expression of LYZ mRNA CTD PMID:15894607 amiodarone increases expression ISO RGD:735254 6480464 Amiodarone results in increased expression of LYZ mRNA CTD PMID:19774075 ammonium chloride affects expression ISO RGD:3026 6480464 Ammonium Chloride affects the expression of LYZ2 mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:3026 6480464 Amphetamine results in increased expression of LYZ2 mRNA CTD PMID:30779732 ampicillin multiple interactions ISO RGD:3026 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein CTD PMID:30545405 antirheumatic drug decreases expression ISO RGD:735254 6480464 Antirheumatic Agents results in decreased expression of LYZ mRNA CTD PMID:24449571 azathioprine decreases expression ISO RGD:735254 6480464 Azathioprine results in decreased expression of LYZ mRNA CTD PMID:22623647 benzene increases expression EXP 6480464 Benzene results in increased expression of LYZ2 mRNA CTD PMID:15120971 , PMID:15122651 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of LYZ2 mRNA CTD PMID:17942131 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of LYZ2 mRNA CTD PMID:23735875 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of LYZ2 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of LYZ2 mRNA] CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LYZ2 mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A decreases expression ISO RGD:3026 6480464 bisphenol A results in decreased expression of LYZ2 mRNA CTD PMID:34947998 bisphenol A affects expression ISO RGD:735254 6480464 bisphenol A affects the expression of LYZ mRNA CTD PMID:30903817 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of LYZ2 mRNA CTD PMID:30951980 bleomycin A2 decreases expression ISO RGD:3026 6480464 Bleomycin results in decreased expression of LYZ protein CTD PMID:25933445 buspirone decreases expression ISO RGD:3026 6480464 Buspirone results in decreased expression of LYZ2 mRNA CTD PMID:24136188 buta-1,3-diene increases expression EXP 6480464 1, 3-butadiene results in increased expression of LYZ2 mRNA CTD PMID:29038090 butyric acid increases expression ISO RGD:735254 6480464 Butyric Acid results in increased expression of LYZ mRNA CTD PMID:34581912 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of LYZ2 mRNA CTD PMID:24067728 cadmium dichloride decreases expression ISO RGD:3026 6480464 Cadmium Chloride results in decreased expression of LYZ2 mRNA CTD PMID:33453195 cadmium dichloride increases expression ISO RGD:3026 6480464 Cadmium Chloride results in increased expression of LYZ2 mRNA CTD PMID:25993096 cadmium dichloride decreases expression ISO RGD:735254 6480464 Cadmium Chloride results in decreased expression of LYZ protein CTD PMID:24419708 calcitriol increases expression ISO RGD:735254 6480464 Calcitriol results in increased expression of LYZ mRNA CTD PMID:16847355 , PMID:26485663 captan decreases expression EXP 6480464 Captan results in decreased expression of LYZ2 mRNA CTD PMID:31558096 carbachol affects secretion ISO RGD:735254 6480464 Carbachol affects the secretion of LYZ protein CTD PMID:15234967 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of LYZ2 mRNA CTD PMID:25620056 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of LYZ2 mRNA CTD PMID:25620056 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LYZ2 mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:735254 6480464 Cisplatin results in increased expression of LYZ mRNA CTD PMID:27594783 cobalt atom multiple interactions ISO RGD:735254 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of LYZ mRNA CTD PMID:18078969 colforsin daropate hydrochloride multiple interactions ISO RGD:735254 6480464 3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone inhibits the reaction [Colforsin results in increased secretion of LYZ protein], [Thapsigargin co-treated with Colforsin] results in increased secretion of LYZ protein CTD PMID:15234967 colforsin daropate hydrochloride decreases secretion ISO RGD:735254 6480464 Colforsin results in decreased secretion of LYZ protein CTD PMID:15194485 colforsin daropate hydrochloride increases secretion ISO RGD:735254 6480464 Colforsin results in increased secretion of LYZ protein CTD PMID:15234967 copper atom decreases expression ISO RGD:3026 6480464 Copper results in decreased expression of LYZ2 mRNA CTD PMID:30556269 copper(0) decreases expression ISO RGD:3026 6480464 Copper results in decreased expression of LYZ2 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:735254 6480464 Copper Sulfate results in decreased expression of LYZ mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of LYZ2 mRNA CTD PMID:18550754 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LYZ mRNA] CTD PMID:18200517 curcumin affects expression ISO RGD:3026 6480464 Curcumin affects the expression of LYZ2 mRNA CTD PMID:18539377 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of LYZ2 mRNA CTD PMID:17942131 cyclosporin A decreases expression ISO RGD:735254 6480464 Cyclosporine results in decreased expression of LYZ mRNA CTD PMID:25562108 , PMID:27989131 cytarabine increases expression ISO RGD:735254 6480464 Cytarabine results in increased expression of LYZ mRNA CTD PMID:19194470 deoxynivalenol decreases expression EXP 6480464 deoxynivalenol results in decreased expression of LYZ protein CTD PMID:34506767 deoxynivalenol multiple interactions EXP 6480464 lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of LYZ protein] CTD PMID:34506767 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of LYZ2 mRNA CTD PMID:21041162 dextran sulfate increases expression EXP 6480464 Dextran Sulfate results in increased expression of LYZ2 mRNA CTD PMID:23894361 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of LYZ2 mRNA CTD PMID:21266533 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of LYZ2 mRNA CTD PMID:26934552 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of LYZ2 mRNA CTD PMID:21041162 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of LYZ2 mRNA CTD PMID:24205000 dodecanoic acid multiple interactions EXP 6480464 lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of LYZ protein] CTD PMID:34506767 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of LYZ2 mRNA CTD PMID:15033991 endosulfan increases expression ISO RGD:3026 6480464 Endosulfan results in increased expression of LYZ2 mRNA CTD PMID:29391264 ethanol multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LYZ2 mRNA CTD PMID:30517762 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of LYZ2 mRNA CTD PMID:11798191 ferric oxide decreases expression EXP 6480464 ferric oxide analog results in decreased expression of LYZ2 mRNA CTD PMID:25086211 ferroheme b increases secretion ISO RGD:735254 6480464 Heme analog results in increased secretion of LYZ protein CTD PMID:23355332 ferroheme b multiple interactions ISO RGD:735254 6480464 SB 203580 inhibits the reaction [Heme analog results in increased secretion of LYZ protein] CTD PMID:23355332 flutamide decreases expression ISO RGD:3026 6480464 Flutamide results in decreased expression of LYZ2 mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LYZ2 mRNA CTD PMID:20938992 folpet decreases expression EXP 6480464 folpet results in decreased expression of LYZ2 mRNA CTD PMID:31558096 fumonisin B1 increases expression EXP 6480464 fumonisin B1 results in increased expression of LYZ2 mRNA CTD PMID:16221962 furan increases expression ISO RGD:3026 6480464 furan results in increased expression of LYZ2 mRNA CTD PMID:26194646 , PMID:27387713 gemcitabine decreases expression ISO RGD:735254 6480464 Gemcitabine results in decreased expression of LYZ mRNA CTD PMID:17039268 gentamycin increases expression ISO RGD:3026 6480464 Gentamicins results in increased expression of LYZ mRNA, Gentamicins results in increased expression of LYZ2 mRNA CTD PMID:22061828 , PMID:33387578 gentamycin multiple interactions ISO RGD:3026 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein CTD PMID:30545405 glafenine increases expression ISO RGD:3026 6480464 Glafenine results in increased expression of LYZ2 mRNA CTD PMID:24136188 glyburide decreases secretion ISO RGD:735254 6480464 Glyburide results in decreased secretion of LYZ protein CTD PMID:15234967 glyburide increases secretion ISO RGD:735254 6480464 Glyburide results in increased secretion of LYZ protein CTD PMID:15194485 heme b increases secretion ISO RGD:735254 6480464 Heme analog results in increased secretion of LYZ protein CTD PMID:23355332 heme b multiple interactions ISO RGD:735254 6480464 SB 203580 inhibits the reaction [Heme analog results in increased secretion of LYZ protein] CTD PMID:23355332 hydrogen peroxide increases expression ISO RGD:735254 6480464 Hydrogen Peroxide results in increased expression of LYZ mRNA CTD PMID:34581912 imidacloprid multiple interactions ISO RGD:3026 6480464 Plant Extracts inhibits the reaction [imidacloprid results in decreased activity of LYZ protein] CTD PMID:35398170 imidacloprid decreases activity ISO RGD:3026 6480464 imidacloprid results in decreased activity of LYZ protein CTD PMID:35398170 irinotecan multiple interactions EXP 6480464 [PHY 906 co-treated with Irinotecan] affects the expression of LYZ2 mRNA CTD PMID:32812032 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LYZ2 mRNA CTD PMID:20938992 lead(II) chloride decreases expression ISO RGD:735254 6480464 lead chloride results in decreased expression of LYZ protein CTD PMID:24419708 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of LYZ2 mRNA CTD PMID:18550754 lipopolysaccharide multiple interactions EXP 6480464 pifithrin inhibits the reaction [Lipopolysaccharides results in increased expression of LYZ2 mRNA] CTD PMID:18550754 methapyrilene increases expression ISO RGD:3026 6480464 Methapyrilene results in increased expression of LYZ2 mRNA CTD PMID:30467583 methylmercury chloride increases expression ISO RGD:3026 6480464 methylmercuric chloride results in increased expression of LYZ2 mRNA CTD PMID:31378766 metronidazole multiple interactions ISO RGD:3026 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein CTD PMID:30545405 milrinone increases expression ISO RGD:3026 6480464 Milrinone results in increased expression of LYZ2 mRNA CTD PMID:22936366 Muraglitazar decreases expression ISO RGD:3026 6480464 muraglitazar results in decreased expression of LYZ mRNA CTD PMID:21515302 N-formyl-L-methionyl-L-leucyl-L-phenylalanine increases secretion ISO RGD:3026 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of LYZ protein CTD PMID:9545557 N-methyl-4-phenylpyridinium increases expression ISO RGD:3026 6480464 1-Methyl-4-phenylpyridinium results in increased expression of LYZ2 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions ISO RGD:3026 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LYZ mRNA CTD PMID:28943392 neomycin multiple interactions ISO RGD:3026 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein CTD PMID:30545405 nickel atom increases expression ISO RGD:735254 6480464 Nickel results in increased expression of LYZ mRNA CTD PMID:25583101 nickel subsulfide decreases expression ISO RGD:3026 6480464 nickel subsulfide results in decreased expression of LYZ2 mRNA CTD PMID:21086188 nimesulide decreases expression ISO RGD:3026 6480464 nimesulide results in decreased expression of LYZ2 mRNA CTD PMID:24136188 nitrofen increases expression ISO RGD:3026 6480464 nitrofen results in increased expression of LYZ2 mRNA CTD PMID:33484710 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of LYZ2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:735254 6480464 Acetaminophen results in increased expression of LYZ mRNA CTD PMID:26690555 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LYZ2 mRNA CTD PMID:17942131 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of LYZ2 mRNA CTD PMID:21371552 paraquat decreases expression ISO RGD:3026 6480464 Paraquat results in decreased expression of LYZ2 mRNA CTD PMID:32680482 parthenolide multiple interactions ISO RGD:735254 6480464 [parthenolide co-treated with artemisinin co-treated with Quercetin] inhibits the reaction [15-hydroxy-5 more ... CTD PMID:23355332 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of LYZ2 mRNA] CTD PMID:19482888 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of LYZ2 mRNA CTD PMID:19482888 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of LYZ2 mRNA CTD PMID:17426115 , PMID:18445702 pirinixic acid decreases expression ISO RGD:3026 6480464 pirinixic acid results in decreased expression of LYZ mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:3026 6480464 Pregnenolone Carbonitrile results in decreased expression of LYZ mRNA CTD PMID:19162173 progesterone multiple interactions ISO RGD:735254 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of LYZ mRNA CTD PMID:20660070 progesterone affects expression EXP 6480464 Progesterone affects the expression of LYZ mRNA CTD PMID:17251523 quercetin decreases expression ISO RGD:735254 6480464 Quercetin results in decreased expression of LYZ mRNA CTD PMID:21632981 quercetin multiple interactions ISO RGD:735254 6480464 [parthenolide co-treated with artemisinin co-treated with Quercetin] inhibits the reaction [15-hydroxy-5 more ... CTD PMID:23355332 resveratrol decreases expression ISO RGD:3026 6480464 resveratrol results in decreased expression of LYZ mRNA CTD PMID:19228061 rotenone increases expression EXP 6480464 Rotenone results in increased expression of LYZ2 mRNA CTD PMID:23186747 SB 203580 multiple interactions ISO RGD:735254 6480464 SB 203580 inhibits the reaction [15-hydroxy-5 more ... CTD PMID:23355332 senecionine increases expression EXP 6480464 senecionine results in increased expression of LYZ2 protein CTD PMID:35357534 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of LYZ2 mRNA CTD PMID:31233874 , PMID:36209798 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of LYZ2 protein CTD PMID:29044176 streptozocin increases expression ISO RGD:3026 6480464 Streptozocin results in increased expression of LYZ mRNA CTD PMID:16684804 streptozocin multiple interactions ISO RGD:3026 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LYZ mRNA] CTD PMID:16684804 T-2 toxin increases expression ISO RGD:735254 6480464 T-2 Toxin results in increased expression of LYZ mRNA CTD PMID:34581912 Tesaglitazar decreases expression ISO RGD:3026 6480464 tesaglitazar results in decreased expression of LYZ mRNA CTD PMID:21515302 testosterone multiple interactions ISO RGD:3026 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYZ2 mRNA CTD PMID:32741896 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of LYZ mRNA, Carbon Tetrachloride affects the expression of LYZ2 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LYZ2 mRNA CTD PMID:29987408 , PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LYZ2 mRNA CTD PMID:30517762 tetrachloromethane increases expression ISO RGD:3026 6480464 Carbon Tetrachloride results in increased expression of LYZ mRNA CTD PMID:16239168 tetradecane decreases expression ISO RGD:3026 6480464 n-tetradecane results in decreased expression of LYZ protein CTD PMID:17337753 thapsigargin multiple interactions ISO RGD:735254 6480464 [Thapsigargin co-treated with Colforsin] results in increased secretion of LYZ protein CTD PMID:15234967 thapsigargin increases secretion ISO RGD:735254 6480464 Thapsigargin results in increased secretion of LYZ protein CTD PMID:15234967 thioacetamide increases expression ISO RGD:3026 6480464 Thioacetamide results in increased expression of LYZ2 mRNA CTD PMID:16337175 , PMID:34492290 thioacetamide multiple interactions ISO RGD:3026 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LYZ mRNA CTD PMID:28943392 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of LYZ2 mRNA CTD PMID:27760801 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of LYZ2 mRNA CTD PMID:17942131 trichloroethene increases expression ISO RGD:3026 6480464 Trichloroethylene results in increased expression of LYZ2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:735254 6480464 trichostatin A results in increased expression of LYZ mRNA CTD PMID:17000900 triphenyl phosphate decreases expression ISO RGD:3026 6480464 triphenyl phosphate results in decreased expression of LYZ2 mRNA CTD PMID:30589522 triptonide increases expression EXP 6480464 triptonide results in increased expression of LYZ2 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of LYZ mRNA CTD PMID:28973697 troglitazone decreases expression ISO RGD:3026 6480464 troglitazone results in decreased expression of LYZ mRNA CTD PMID:21515302 trovafloxacin decreases expression ISO RGD:3026 6480464 trovafloxacin results in decreased expression of LYZ2 mRNA CTD PMID:24136188 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of LYZ2 mRNA CTD PMID:35537566 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of LYZ2 mRNA CTD PMID:30912803 Tungsten carbide multiple interactions ISO RGD:735254 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of LYZ mRNA CTD PMID:18078969 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of LYZ2 mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:735254 6480464 Valproic Acid results in decreased expression of LYZ mRNA CTD PMID:29154799 vanadyl sulfate multiple interactions ISO RGD:3026 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LYZ mRNA] CTD PMID:16684804 vancomycin decreases expression EXP 6480464 Vancomycin results in decreased expression of LYZ2 mRNA CTD PMID:18930951 vancomycin multiple interactions ISO RGD:3026 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein CTD PMID:30545405 vinclozolin affects expression ISO RGD:3026 6480464 vinclozolin affects the expression of LYZ mRNA CTD PMID:19015723 vinclozolin increases expression ISO RGD:3026 6480464 vinclozolin results in increased expression of LYZ2 mRNA CTD PMID:23034163